Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 13/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CCKAR | P32238 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9040095 | 0.85 | CCKBR (0.59) | CCKBRALDH1A1CCKAR | |
| SCHEMBL9040117 | 0.85 | CCKBR (0.51) | CCKBRALDH1A1CCKAR | |
| SCHEMBL9039789 | 0.84 | CCKBR (0.65) | CCKBRCCKAR | |
| SCHEMBL9040261 | 0.82 | CCKBR (0.50) | CCKBRALDH1A1CCKAR | |
| SCHEMBL9039509 | 0.81 | CCKBR (0.55) | CCKBRALDH1A1CCKAR | |
| SCHEMBL9041497 | 0.81 | CCKBR (0.71) | CCKBRCCKAR | |
| SCHEMBL9040114 | 0.81 | CCKBR (0.59) | CCKBRCCKAR | |
| SCHEMBL9039519 | 0.81 | CCKBR (0.60) | CCKBRCCKAR | |
| SCHEMBL9038467 | 0.81 | CCKBR (0.56) | CCKBRALDH1A1CCKAR | |
| SCHEMBL9039128 | 0.81 | CCKBR (0.73) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0703222-A1 | 3-AMINOAZEPINE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-03-27 | — | — | EP | claimed |
| EP-0703222-A1 | 3-AMINOAZEPINE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-03-27 | — | — | EP | disclosed |